RÉSUMÉ
Oncogene-induced senescence (OIS) is a stable cell cycle arrest that occurs in normal cells upon oncogene activation. Cells undergoing OIS express a wide variety of secreted factors that affect the senescent microenvironment termed the senescence-associated secretory phenotype (SASP), which is beneficial or detrimental in a context-dependent manner. OIS cells are also characterized by marked epigenetic changes. We globally assessed histone modifications of OIS cells and discovered an increase in the active histone marks H3K79me2/3. The H3K79 methyltransferase disruptor of telomeric silencing 1-like (DOT1L) was necessary and sufficient for increased H3K79me2/3 occupancy at the IL1A gene locus, but not other SASP genes, and was downstream of STING. Modulating DOT1L expression did not affect the cell cycle arrest. Together, our studies establish DOT1L as an epigenetic regulator of the SASP, whose expression is uncoupled from the senescence-associated cell cycle arrest, providing a potential strategy to inhibit the negative side effects of senescence while maintaining the beneficial inhibition of proliferation.
Sujet(s)
Vieillissement de la cellule , Méthylation de l'ADN , Épigenèse génétique , Fibroblastes/enzymologie , Histone-lysine N-methyltransferase/métabolisme , Histone/métabolisme , Interleukine-1 alpha/métabolisme , 7,12-Diméthyl-benzo[a]anthracène , Animaux , Protéine bêta de liaison aux séquences stimulatrices de type CCAAT/génétique , Protéine bêta de liaison aux séquences stimulatrices de type CCAAT/métabolisme , Points de contrôle du cycle cellulaire , Prolifération cellulaire , Femelle , Cellules HEK293 , Histone-lysine N-methyltransferase/génétique , Histone/génétique , Humains , Interleukine-1 alpha/génétique , Protéines membranaires/génétique , Protéines membranaires/métabolisme , Souris , Microscopie de fluorescence , Papillome/induit chimiquement , Papillome/génétique , Papillome/métabolisme , Papillome/anatomopathologie , Phénotype , Voie de sécrétion , Tumeurs cutanées/induit chimiquement , Tumeurs cutanées/génétique , Tumeurs cutanées/métabolisme , Tumeurs cutanées/anatomopathologie , 12-Myristate-13-acétate de phorbolRÉSUMÉ
The process of phagophore closure requires the endosomal sorting complex required for transport III (ESCRT-III) subunit CHMP2A and the AAA ATPase VPS4, but their regulatory mechanisms remain unknown. Here, we establish a FACS-based HaloTag-LC3 autophagosome completion assay to screen a genome-wide CRISPR library and identify the ESCRT-I subunit VPS37A as a critical component for phagophore closure. VPS37A localizes on the phagophore through the N-terminal putative ubiquitin E2 variant domain, which is found to be required for autophagosome completion but dispensable for ESCRT-I complex formation and the degradation of epidermal growth factor receptor in the multivesicular body pathway. Notably, loss of VPS37A abrogates the phagophore recruitment of the ESCRT-I subunit VPS28 and CHMP2A, whereas inhibition of membrane closure by CHMP2A depletion or VPS4 inhibition accumulates VPS37A on the phagophore. These observations suggest that VPS37A coordinates the recruitment of a unique set of ESCRT machinery components for phagophore closure in mammalian cells.